Literature DB >> 28628823

Drug development against tuberculosis: Impact of alkaloids.

Shardendu K Mishra1, Garima Tripathi2, Navneet Kishore2, Rakesh K Singh3, Archana Singh2, Vinod K Tiwari4.   

Abstract

Despite of the advances made in the treatment and management, tuberculosis (TB) still remains one of main public health problem. The contrary effects of first and second-line anti-tuberculosis drugs have generated extended research interest in natural products in the hope of devising new antitubercular leads. Interestingly, plethoras of natural products have been discovered to exhibit activity towards various resistant strains of M. tuberculosis. Extensive applications of alkaloids in the field of therapeutics is well-established and nowday's researches being pursued to develop new potent drugs from natural sources for tuberculosis. Alkaloids are categorized in quite a few groups according to their structures and isolation from both terrestrial and marine sources. These new drugs might be a watershed in the battle against tuberculosis. This review summarizes alkaloids, which were found active against Mycobacteria since last ten years with special attention on the study of structure-activity relationship (SAR) and mode of action with their impact in drug discovery and development against tuberculosis.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Alkaloids; Antimycobacterial agents; Drug development; Multi drug resistant tuberculosis; Mycobacterium tuberculosis; Natural products; Tuberculosis

Mesh:

Substances:

Year:  2017        PMID: 28628823     DOI: 10.1016/j.ejmech.2017.06.005

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  6 in total

1.  Alkaloids of Dicranostigma franchetianum (Papaveraceae) and Berberine Derivatives as a New Class of Antimycobacterial Agents.

Authors:  Viriyanata Wijaya; Ondřej Janďourek; Jana Křoustková; Kateřina Hradiská-Breiterová; Jan Korábečný; Kateřina Sobolová; Eliška Kohelová; Anna Hošťálková; Klára Konečná; Marcela Šafratová; Rudolf Vrabec; Jiří Kuneš; Lubomír Opletal; Jakub Chlebek; Lucie Cahlíková
Journal:  Biomolecules       Date:  2022-06-17

2.  Investigation of Copaifera genus as a new source of antimycobaterial agents.

Authors:  Jéssica Aparecida Alves; Fariza Abrão; Thaís da Silva Moraes; Jaqueline Lopes Damasceno; Marcos Fernando Dos Santos Moraes; Rodrigo Cassio Sola Veneziani; Sérgio Ricardo Ambrósio; Jairo Kenupp Bastos; Mayker Lázaro Dantas Miranda; Carlos Henrique Gomes Martins
Journal:  Future Sci OA       Date:  2020-05-29

3.  Antimycobacterial Activity and Safety Profile Assessment of Alpinia galanga and Tinospora cordifolia.

Authors:  Mohamed F Alajmi; Ramzi A Mothana; Adnan J Al-Rehaily; Jamal M Khaled
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-08       Impact factor: 2.629

4.  Semisynthetic Derivatives of Selected Amaryllidaceae Alkaloids as a New Class of Antimycobacterial Agents.

Authors:  Negar Maafi; Abdullah Al Mamun; Ondřej Janďourek; Jana Maříková; Kateřina Breiterová; Adéla Diepoltová; Klára Konečná; Anna Hošťálková; Daniela Hulcová; Jiří Kuneš; Eliška Kohelová; Darja Koutová; Marcela Šafratová; Lucie Nováková; Lucie Cahlíková
Journal:  Molecules       Date:  2021-10-04       Impact factor: 4.411

5.  Screening of Microbial Fermentation Products for Anti-M. tuberculosis Activity.

Authors:  Aikebaier Reheman; Di Lu; Yifan Wang; Xi Chen; Gang Cao; Chuanxing Wan
Journal:  Animals (Basel)       Date:  2022-07-31       Impact factor: 3.231

6.  Investigating the Antituberculosis Activity of Selected Commercial Essential Oils and Identification of Active Constituents Using a Biochemometrics Approach and In Silico Modeling.

Authors:  Katyna J Boussamba-Digombou; Maxleene Sandasi; Guy P Kamatou; Sandy van Vuuren; Rafal Sawicki; Zeynab Fakhar; Alvaro M Viljoen
Journal:  Antibiotics (Basel)       Date:  2022-07-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.